Adium (Adium Paraguay / Fapasa)

Adium is a leading pharmaceutical group in Latin America with over 50 years of experience, dedicated to the development, manufacturing, and marketing of high-quality pharmaceutical products. The company operates in 18 countries across the region, maintaining a strong focus on both general medicine and specialized therapeutic areas such as oncology and rare diseases. Adium distinguishes itself through a hybrid model that combines its own portfolio of products with strategic licensing agreements. It serves as a key partner for multinational pharmaceutical and biotechnology companies, providing them with access to the Latin American market. The company operates major production facilities in Argentina, Paraguay, Brazil, Mexico, and Uruguay, producing over 120 million units annually.